Serum soluble signal regulatory protein alpha as a potential prognostic biomarker after surgery for esophageal cancer
Clinical Immunology · 2026-12 · 288 · 110784
DOI: 10.1016/j.clim.2026.110784 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2026-12. Verfasst von Kristian W Antonsen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark…. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oda and Hans Svenningsen's Fund, Aarhus University.
Abstract (Originalsprache)
Signal Regulatory Protein Alpha (SIRPα) and CD163 are associated with prognosis in esophageal cancer, but their prognostic value in blood is unknown. We retrospectively analyzed a randomized controlled trial of patients undergoing surgery for esophageal cancer. Soluble SIRPα (sSIRPα) and CD163 (sCD163) were measured using enzyme-linked immunosorbent assays in serum collected on the day of surgery and postoperative day 30. Patients were followed for one year. 68 patients were included. In patients undergoing upfront surgery (n = 15), high sSIRPα predicted increased 1-year mortality and sSIRPα 26.15 μg/L identified a low-risk subgroup (N = 31/53, 58.5%) with 100% 1-year survival. There was no prognostic value in sCD163. In conclusion, neoadjuvant treatment may influence the prognostic value of sSIRPα in esophageal cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: Kriant@rm.dk.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Abdominal Surgery, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Förderung
- Oda and Hans Svenningsen's Fund
- Aarhus University
Zitieren
APA
Antonsen, K. W., Katballe, N., Kjær, D. W., Christensen, T. D., Møller, H. J., & Gyldenholm, T. (2026). Serum soluble signal regulatory protein alpha as a potential prognostic biomarker after surgery for esophageal cancer. Clinical Immunology, 288, 110784. https://doi.org/10.1016/j.clim.2026.110784
Vancouver
Antonsen KW, Katballe N, Kjær DW, Christensen TD, Møller HJ, Gyldenholm T. Serum soluble signal regulatory protein alpha as a potential prognostic biomarker after surgery for esophageal cancer. Clinical Immunology. 2026;288:110784. doi:10.1016/j.clim.2026.110784
BibTeX
@article{Antonsen2026,
author = {Antonsen, Kristian W and Katballe, Niels and Kjær, Daniel W and Christensen, Thomas D and Møller, Holger J and Gyldenholm, Tua},
title = {Serum soluble signal regulatory protein alpha as a potential prognostic biomarker after surgery for esophageal cancer},
journal = {Clinical Immunology},
year = {2026},
volume = {288},
pages = {110784},
doi = {10.1016/j.clim.2026.110784}
}
EUVIMED